Comparative Pharmacology
Head-to-head clinical analysis: HIPPUTOPE versus MACROTEC.
Peer-Reviewed Evidence
Head-to-head clinical analysis: HIPPUTOPE versus MACROTEC.
HIPPUTOPE vs MACROTEC
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
HIPPUTOPE is a diagnostic agent used to assess renal function. It is a radiolabeled compound that undergoes glomerular filtration and tubular secretion, allowing measurement of renal plasma flow and tubular function via imaging.
Not applicable for diagnostic use.
100-300 microcuries (3.7-11.1 MBq) intravenous, single dose for renal imaging.
5 mCi (185 MBq) intravenously as a single dose for lung perfusion imaging.
None Documented
None Documented
Terminal elimination half-life is 1.5–2.5 hours; prolonged to 6–12 hours in moderate-to-severe renal impairment (CrCl <30 mL/min).
6 hours; prolonged in renal impairment (up to 30 hours in ESRD)
Primarily renal excretion (approximately 90% as unchanged drug via glomerular filtration), with minor biliary/fecal elimination (<10%).
Renal: 95% as unchanged drug; biliary/fecal: <5% as metabolites
Category C
Category C
Radiopharmaceutical
Radiopharmaceutical